OpenVSafe by OpenVAERS
Search V-safe

AD4-31862-94920

3 vaccinations 8 coded responses 28 check-ins 8 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
902 / CA
Registered
2020-12-23
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Moderna
  3. 2020-12-23
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  4. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  5. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  7. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2020-12-27
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  10. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  11. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Fair · Site: Itching · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  12. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  13. 2021-01-13
    Survey response — day 21, dose 1
    MedDRA: Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work
    Free text: A sore throat, mild. Nasal congestion, clear discharge, trace amounts
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-13
    Report sent to call center — day 21, dose 1
    Be unable to work
    1 call case(s)
  15. 2021-01-20
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  16. 2021-01-23
    Dose 2 — Moderna
  17. 2021-01-23
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  18. 2021-01-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  19. 2021-01-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Muscle or body aches
    Adult check-in
  21. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  22. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Itching · Headache
    Adult check-in
  23. 2021-01-30
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  24. 2021-02-06
    Survey response — day 14, dose 2
    MedDRA: Glossodynia, Hypoaesthesia, Rhinorrhoea — Feeling: Good
    Free text: Numbness, mild pains on side of tongue; rhinorrhea
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-02-13
    Survey response — day 21, dose 2
    MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, mild nasal congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-02-20
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-02-28
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-03-08
    Survey response — day 42, dose 2
    MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Rhinorrhoea, Upper-airway cough syndrome — Feeling: Good · Be unable to work
    Free text: Nasal congestion, runny nose, sore throat from post nasal drip, occasional cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-04-25
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-07-24
    Survey response — 6 months, dose 2
    MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school
    Free text: Stuffy nose , mild sore throat
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  31. 2021-12-10
    Dose 3 — Moderna
  32. 2022-01-23
    Survey response — 12 months, dose 2
    MedDRA: Respiratory syncytial virus infection, Upper respiratory tract infection — Feeling: Good
    Free text: Upper respiratory infection likely RSV
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-06-10
    Survey response — 6 months, dose 3
    MedDRA: Diarrhoea, Nasal congestion, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Have had diarrhea, have had runny noses, nasal congestion
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-12-10
    Survey response — 12 months, dose 3
    MedDRA: Pyrexia, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: A few mild upper respiratory infections. Also a separate episode of fever
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Moderna
22021-01-23Moderna
32021-12-10Moderna No

Call center

2 call center cases

2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 21, dose 1

2021-01-13

Symptoms: A sore throat, mild. Nasal congestion, clear discharge, trace amounts

Release 3 — day 14, dose 2

2021-02-06

Symptoms: Numbness, mild pains on side of tongue; rhinorrhea

Release 4 — day 21, dose 2

2021-02-13

Symptoms: Runny nose, mild nasal congestion

Release 5 — day 42, dose 2

2021-03-08

Symptoms: Nasal congestion, runny nose, sore throat from post nasal drip, occasional cough

Release 9 — 6 months, dose 2

2021-07-24

Symptoms: Stuffy nose , mild sore throat

Release 11 — 12 months, dose 2

2022-01-23

Symptoms: Upper respiratory infection likely RSV

Release 12 — 6 months, dose 3

2022-06-10

Symptoms: Have had diarrhea, have had runny noses, nasal congestion

Release 12 — 12 months, dose 3

2022-12-10

Symptoms: A few mild upper respiratory infections. Also a separate episode of fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ ✓ ✓
SDDiarrhoea · · ✓
SDGlossodynia ✓ ✓ ✓
SDHypoaesthesia ✓ ✓ ✓
SDNasal congestion ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPyrexia · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRhinorrhoea ✓ ✓ ✓
SDUpper respiratory tract infection · · ✓
SDUpper-airway cough syndrome ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release